Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes von Cheah, C.Y., Chihara, D., Romaguera, J.E., Fowler, N.H., Seymour, J.F., Hagemeister, F.B., Champlin, R.E., Wang, M.L.

Volltext

Breakthrough therapies in B-cell non-Hodgkin lymphoma von Cheah, C.Y., Fowler, N.H., Wang, M.L.

Volltext

Role of the tumor microenvironment in mature B-cell lymphoid malignancies von Fowler, Nathan H, Cheah, Chan Yoon, Gascoyne, Randy D, Gribben, John, Neelapu, Sattva S, Ghia, Paolo, Bollard, Catherine, Ansell, Stephen, Curran, Michael, Wilson, Wyndham H, O'Brien, Susan, Grant, Cliona, Little, Richard, Zenz, Thorsten, Nastoupil, Loretta J, Dunleavy, Kieron

Volltext

Unmet needs in the first-line treatment of follicular lymphoma von Casulo, C., Nastoupil, L., Fowler, N.H., Friedberg, J.W., Flowers, C.R.

Volltext

Autologous stem cell transplantation for untreated transformed indolent B‐cell lymphoma in first remission: an international, multi‐centre propensity‐score‐matched study von Chin, C. K., Lim, K. J., Lewis, K., Jain, P., Qing, Y., Feng, L., Cheah, C. Y., Seymour, J. F., Ritchie, D., Burbury, K., Tam, C. S., Fowler, N. H., Fayad, L. E., Westin, J. R., Neelapu, S. S., Hagemeister, F. B., Samaniego, F., Flowers, C. R., Nastoupil, L. J., Dickinson, M. J.

Volltext

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era von Cheah, C.Y., Chihara, D., Ahmed, M., Davis, R.E., Nastoupil, L.J., Phansalkar, K., Hagemeister, F.B., Fayad, L.E., Westin, J.R., Oki, Y., Fanale, M.A., Romaguera, J.E., Wang, M.L., Lee, H., Turturro, F., Samaniego, F., Rodriguez, M.A., Neelapu, S.S., Fowler, N.H.

Volltext

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes von Cheah, C.Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N.H., Romaguera, J.E., Turturro, F., Hagemeister, F.B., Fayad, L.E., Wang, M., Neelapu, S.S., Nastoupil, L.J., Westin, J.R., Rodriguez, M.A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M.A.

Volltext

EFFICACY AND SAFETY OF TISAGENLECLEUCEL (TISA‐CEL) IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): PRIMARY ANALYSIS OF THE PHASE 2 ELARA TRIAL von Schuster, S. J., Dickinson, M., Dreyling, M., Martinez‐Lopez, J., Kolstad, A., Butler, J., Ghosh, M., Popplewell, L., Chavez, J. C., Bachy, E., Kato, K., Harigae, H., Kersten, M. José, Andreadis, C., Riedell, P. A., Abdelhady, A., Zia, A., Morisse, M. C., Fowler, N. H., Thieblemont, C.

Volltext

PATIENT‐REPORTED QUALITY OF LIFE (QOL) FOLLOWING TISAGENLECLEUCEL (TISA‐CEL) INFUSION IN ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL) von Fowler, N. H., Dickinson, M., Martinez‐Lopez, J., Kolstad, A., Schuster, S. J., Dreyling, M., Ghosh, M., Harigae, H., Kersten, M. José, Bachy, E., Popplewell, L., Chavez, J. C., Ho, P. J., Butler, J., Kato, K., von Tresckow, B., Ferreri, A. J. M., Simón, J. A. P., Patten, P. E. M., Andreadis, C., Riedell, P. A., McGuirk, J. P., Nastoupil, L. J., Teshima, T., Offner, F., Petzer, A., Viardot, A., Zinzani, P. L., Malladi, R., Zhang, J., Tiwari, R., Bollu, V., Masood, A., Thieblemont, C.

Volltext

Tisagenlecleucel Is Safe and Effective in Relapsed/Refractory Follicular Lymphoma

Volltext

PI3Kδ-CK1ε Inhibitor Umbralisib Shows Promise in R/R Indolent NHL

Volltext

Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma von Fowler, Nathan H, Nastoupil, Loretta J, Hagemeister, Frederick B, Neelapu, Sattva S, Fayad, Luis E, LeBlanc, Denise, Samaniego, Felipe, Cheah, Chan Yoon

Volltext

AUGMENT: RELAPSED/REFRACTORY INDOLENT NHL PATIENTS WERE MORE SENSITIVE TO NEXT TREATMENT FOLLOWING LENALIDOMIDE/RITUXIMAB (R2) THAN RITUXIMAB/PLACEBO von Gribben, J., Trneny, M., Izutsu, K., Fowler, N.H., Hong, X., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G., Pinto, A., Re, F., Fogliatto, L., Scheinberg, P., Flinn, I., Moreira, C., Czuczman, M., Kalambakas, S., Fustier, P., Wu, C., Leonard, J.

Volltext

HEALTH‐RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2) VERSUS R PLUS PLACEBO von Leonard, J.P., Trněny, M., Izutsu, K., Fowler, N.H., Hong, X., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G., Pinto, A., Re, F., Fogliatto, L.M., Scheinberg, P., Flinn, I.W., Moreira, C., Tabah, A., Abouzaid, S., Kalambakas, S., Fustier, P., Wu, C., Gribben, J.G.

Volltext

High response rates with lenalidomide plus rituximab for untreated indolent B-cell non-Hodgkin lymphoma, including those meeting GELF criteria von Samaniego, F., Hagemeister, F., Mclaughlin, P., Kwak, L. W., Romaguera, J., Fanale, M. A., Neelapu, S. S., Fayad, L., Orlowski, R. Z., Wang, M., Lacerte, L., Fowler, N. H.

Volltext

Effect of Btk inhibitor PCI-32765 monotherapy on responses in patients with relapsed aggressive NHL: Evidence of antitumor activity from a phase I study von Advani, R., Sharman, J. P., Smith, S. M., Pollyea, D. A., Boyd, T. E., Grant, B. W., Kolibaba, K. S., Buggy, J. J., Hamdy, A., Fowler, N. H.

Volltext

Complete response rates with lenalidomide plus rituximab for untreated indolent B-cell non-Hodgkin's lymphoma von Fowler, N. H., McLaughlin, P., Hagemeister, F. B., Kwak, L. W., Fanale, M. A., Neelapu, S. S., Fayad, L., Orlowski, R. Z., Wang, M., Samaniego, F.

Volltext

Diffuse large B-cell lymphoma (DLBCL) with bone marrow (BM) involvement. clinical presentation, central nervous system (CNS) relapses, and outcomes of 121 patients treated at M. D.... von Perini, G. F., Romaguera, J. E., Rodriguez, M. A., Pro, B., Younes, A., Fowler, N. H., Hagemeister, F. B., Samaniego, F., Kwak, L. W., Fayad, L.

Volltext

Lenalidomide and rituximab for untreated indolent non-Hodgkin's lymphoma von Fowler, N. H., McLaughlin, P., Kwak, L., Hagemeister, F., Fanale, M., Fayad, L., Pro, B., Samaniego, F.

Volltext

UMBRALISIB MONOTHERAPY DEMONSTRATES EFFICACY AND SAFETY IN PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA: A MULTICENTER, OPEN‐LABEL, REGISTRATION DIRECTED PHASE 2 STUDY... von Zinzani, P., Samaniego, F., Jurczak, W., Lech‐Maranda, E., Ghosh, N., Anz, B., Patten, P., Reeves, J., Leslie, L.A., Smolewski, P., Chavez, J.C., Scarfo, L., Derenzini, E., Burke, J.M., Sharman, J., Kolibaba, K., O'Connor, O.A., Cheah, C.Y., Miskin, H.P., Sportelli, P., Weiss, M.S., Fowler, N.H.

Volltext